Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 double-blind study of ASP2151 vs valaciclovir in herpes zoster
jRCT2080222242Phase 3
- Sponsor
- Maruho Co., Ltd.
- Start
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Amenamevir in herpes zoster (HZ) (3 arms), sponsored by Maruho Co., Ltd.
02
Drugs
Amenamevir
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on jRCT2080222242.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222242.